{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1382544419738589058.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Masahiro Kobayashi"}],"foaf:familyName":[{"@value":"Kobayashi"}],"foaf:givenName":[{"@value":"Masahiro"}]}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1362544419738589056","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1111/j.1440-1746.2008.05760.x"},{"@type":"URI","@value":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1440-1746.2008.05760.x"},{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1440-1746.2008.05760.x"},{"@type":"PMID","@value":"19226381"}],"notation":[{"@value":"Efficacy of entecavir treatment for lamivudine‐resistant hepatitis B over 3 years: Histological improvement or entecavir resistance?"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1111/j.1440-1746.2008.05760.x_PIPD4iVgvorGbl1eojzAm3sQlEQ"},{"@type":"OPENAIRE","@value":"doi_dedup___::b8323bb7d378a7cc936cbd3693c55296_PIPD4iVgvorGbl1eojzAm3sQlEQ"}]}